Cargando…

A Novel Prediction Model of Acute Kidney Injury Based on Combined Blood Variables in STEMI

BACKGROUND: Development of acute kidney injury (AKI) is associated with poor prognosis in patients with ST-segment elevation myocardial infarction (STEMI). OBJECTIVE: This study sought to investigate whether a combination of pre-procedural blood tests could predict the incidence of AKI in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goriki, Yuhei, Tanaka, Atsushi, Nishihira, Kensaku, Kuriyama, Nehiro, Shibata, Yoshisato, Node, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627908/ https://www.ncbi.nlm.nih.gov/pubmed/36341223 http://dx.doi.org/10.1016/j.jacasi.2021.07.013

Ejemplares similares

Development of a Laboratory Risk-Score Model to Predict One-Year Mortality in Acute Myocardial Infarction Survivors
por: Goriki, Yuhei, et al.
Publicado: (2022)

A Novel Predictive Model for In-Hospital Mortality Based on a Combination of Multiple Blood Variables in Patients with ST-Segment-Elevation Myocardial Infarction
por: Goriki, Yuhei, et al.
Publicado: (2020)

Impact of 1 month of intensive lipid-lowering therapy on plaque composition evaluated using near-infrared spectroscopy
por: Nishihira, Kensaku, et al.
Publicado: (2021)

Ruptured lipid-rich plaque in a saphenous vein graft causing no-reflow phenomenon: insights from near-infrared spectroscopy, optical coherence tomography, and histopathological analysis
por: Nishihira, Kensaku, et al.
Publicado: (2021)

ST-Elevation Myocardial Infarction With Cardiogenic Shock and Severe Acute Ischemic Mitral Regurgitation Rescued by Primary Coronary Intervention Under Hemodynamic Support With Impella
por: Koiwaya, Hiroshi, et al.
Publicado: (2021)

Visualization of a Rapidly Progressing Lipid-Rich Plaque Causing No-Reflow Phenomenon During Percutaneous Coronary Intervention　― Insights From Near-Infrared Spectroscopy and Histopathology ―
por: Honda, Yasuhiro, et al.
Publicado: (2019)

Prognostic Impact of Serum Albumin for Developing Heart Failure Remotely after Acute Myocardial Infarction
por: Yoshioka, Goro, et al.
Publicado: (2020)

Septic pulmonary embolism caused by infected adherent fibrous tissue after percutaneous lead extraction
por: Tsumagari, Yasuaki, et al.
Publicado: (2023)

Prognostic impact of follow‐up serum albumin after acute myocardial infarction
por: Yoshioka, Goro, et al.
Publicado: (2021)

Prognostic impact of incident left ventricular systolic dysfunction after myocardial infarction
por: Yoshioka, Goro, et al.
Publicado: (2022)

Lotus Root-Like Appearance of a Lipid-Rich Plaque in a Patient With Acute Myocardial Infarction　― Findings From Near-Infrared Spectroscopy and Optical Coherence Tomography ―
por: Nishihira, Kensaku, et al.
Publicado: (2021)

Outcomes of Elderly Patients With Acute Myocardial Infarction and Heart Failure Who Undergo Percutaneous Coronary Intervention
por: Nishihira, Kensaku, et al.
Publicado: (2022)

Intra- and Postprocedural Management of Coronary Artery Perforation During Percutaneous Coronary Intervention
por: Matsuura, Hirohide, et al.
Publicado: (2022)

Left main coronary artery embolism caused by BioGlue surgical adhesive after type A acute aortic dissection repair: intracoronary imaging and histopathological analysis
por: Yamamoto, Keisuke, et al.
Publicado: (2023)

Successful sealing of a coronary aneurysm by novel, second-generation, covered stent implantation: first report of optical coherence tomography and coronary angioscopy evaluation
por: Koiwaya, Hiroshi, et al.
Publicado: (2021)

Pathological findings of a distal embolus during laser atherectomy for in-stent occlusion of the superficial femoral artery
por: Ogata, Kenji, et al.
Publicado: (2023)

Chlamydia pneumoniae is Prevalent in Symptomatic Coronary Atherosclerotic Plaque Samples Obtained From Directional Coronary Atherectomy, but its Quantity is Not Associated With Plaque Instability: An Immunohistochemical and Molecular Study
por: Otani, Tomoyuki, et al.
Publicado: (2022)

Pathological Features of Ruptured Coronary Plaque and Thrombus Interfaces: Fibrin and von Willebrand Factor as Platelet Scaffolds on Rupture Sites
por: Yamashita, Atsushi, et al.
Publicado: (2021)

Involvement of enhanced expression of classical complement C1q in atherosclerosis progression and plaque instability: C1q as an indicator of clinical outcome
por: Sasaki, Shoh, et al.
Publicado: (2022)

α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study
por: Shimabukuro, Michio, et al.
Publicado: (2017)

Collective Knowledge Used to Unveil Cardiovascular Injury Emerged during COVID-19
por: Tanaka, Atsushi, et al.
Publicado: (2022)

Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case Report
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Impact of febuxostat on visit-to-visit blood pressure variability: insights from the randomised PRIZE Study
por: Saito, Yuichi, et al.
Publicado: (2022)

Neopterin as a Marker of In-Stent Restenosis: to Have or Have Not
por: Nishihira, Kensaku
Publicado: (2018)

Prediction of Stroke After Cardiac Catheterization: No Reason, No Stroke
por: Tanaka, Atsushi, et al.
Publicado: (2018)

Increased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit?
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials
por: Tanaka, Atsushi, et al.
Publicado: (2018)

Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure
por: Tanaka, Atsushi, et al.
Publicado: (2018)

Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials
por: Tanaka, Atsushi, et al.
Publicado: (2019)

Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care
por: Tanaka, Atsushi, et al.
Publicado: (2020)

How should we monitor the cardiovascular benefit of sodium–glucose cotransporter 2 inhibition?
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Crosstalk between the liver and heart: revisited for prevention and treatment
por: Tanaka, Atsushi, et al.
Publicado: (2020)

The Emerging and Promising Role of Care for Cardiometabolic Syndrome in Prostate Cancer
por: Tanaka, Atsushi, et al.
Publicado: (2019)

Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors
por: Tanaka, Atsushi, et al.
Publicado: (2021)

In‐hospital therapy for worsening heart failure: black box or sweet spot?
por: Tanaka, Atsushi, et al.
Publicado: (2021)

So‐far overlooked HFpEF patients with normal natriuretic peptide level need more evidence
por: Tanaka, Atsushi, et al.
Publicado: (2022)

What More Can Be Delivered to Future Patients with Coronary Syndromes?
por: Tanaka, Atsushi, et al.
Publicado: (2022)

STEMI or non-STEMI: that is the question
por: Camaro, Cyril, et al.
Publicado: (2015)

Histopathology of Asymptomatic Iliac Atherosclerosis: From Autopsy to Practice
por: Nishihira, Kensaku, et al.
Publicado: (2017)

Hypertension, Blood Pressure Variability, and Acute Kidney Injury in Hospitalized Children
por: Nugent, James T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hral30d8ptaa7mu7n8d6c3kge6